nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—SLC22A5—Dactinomycin—muscle cancer	0.366	0.576	CbGbCtD
Epinephrine—CYP1A2—Dacarbazine—muscle cancer	0.123	0.193	CbGbCtD
Epinephrine—CYP1A2—Etoposide—muscle cancer	0.06	0.0943	CbGbCtD
Epinephrine—CYP3A4—Vincristine—muscle cancer	0.0343	0.0539	CbGbCtD
Epinephrine—CYP3A4—Etoposide—muscle cancer	0.0314	0.0494	CbGbCtD
Epinephrine—CYP3A4—Doxorubicin—muscle cancer	0.0214	0.0337	CbGbCtD
Epinephrine—Skin necrosis—Etoposide—muscle cancer	0.0067	0.0434	CcSEcCtD
Epinephrine—Tachyarrhythmia—Doxorubicin—muscle cancer	0.00665	0.043	CcSEcCtD
Epinephrine—ADRBK1—embryo—muscle cancer	0.00651	0.0736	CbGeAlD
Epinephrine—PAH—renal system—muscle cancer	0.00645	0.073	CbGeAlD
Epinephrine—TNF—vagina—muscle cancer	0.00621	0.0703	CbGeAlD
Epinephrine—Cerebral haemorrhage—Vincristine—muscle cancer	0.00522	0.0338	CcSEcCtD
Epinephrine—ADRBK1—smooth muscle tissue—muscle cancer	0.00512	0.0579	CbGeAlD
Epinephrine—Lactic acidosis—Doxorubicin—muscle cancer	0.00497	0.0322	CcSEcCtD
Epinephrine—ADRBK1—renal system—muscle cancer	0.00492	0.0557	CbGeAlD
Epinephrine—Nephropathy—Etoposide—muscle cancer	0.00492	0.0318	CcSEcCtD
Epinephrine—PAH—head—muscle cancer	0.00432	0.0488	CbGeAlD
Epinephrine—Necrosis—Dactinomycin—muscle cancer	0.00412	0.0267	CcSEcCtD
Epinephrine—Skin necrosis—Methotrexate—muscle cancer	0.00401	0.026	CcSEcCtD
Epinephrine—ADRBK1—bone marrow—muscle cancer	0.00372	0.0421	CbGeAlD
Epinephrine—Extravasation—Dactinomycin—muscle cancer	0.00371	0.024	CcSEcCtD
Epinephrine—ADRBK1—vagina—muscle cancer	0.00357	0.0403	CbGeAlD
Epinephrine—Skin necrosis—Doxorubicin—muscle cancer	0.00348	0.0225	CcSEcCtD
Epinephrine—Rales—Methotrexate—muscle cancer	0.00342	0.0221	CcSEcCtD
Epinephrine—Hemiplegia—Doxorubicin—muscle cancer	0.0034	0.022	CcSEcCtD
Epinephrine—Extravasation—Vincristine—muscle cancer	0.00331	0.0214	CcSEcCtD
Epinephrine—ADRBK1—head—muscle cancer	0.00329	0.0373	CbGeAlD
Epinephrine—ADRBK1—testis—muscle cancer	0.00318	0.036	CbGeAlD
Epinephrine—Drug interaction—Vincristine—muscle cancer	0.00312	0.0202	CcSEcCtD
Epinephrine—SLC22A2—renal system—muscle cancer	0.00303	0.0343	CbGeAlD
Epinephrine—Necrosis—Etoposide—muscle cancer	0.00298	0.0193	CcSEcCtD
Epinephrine—Nephropathy—Methotrexate—muscle cancer	0.00295	0.0191	CcSEcCtD
Epinephrine—Tingling sensation—Etoposide—muscle cancer	0.00291	0.0188	CcSEcCtD
Epinephrine—ADRA1B—renal system—muscle cancer	0.0029	0.0328	CbGeAlD
Epinephrine—Extravasation—Etoposide—muscle cancer	0.00268	0.0174	CcSEcCtD
Epinephrine—Skin exfoliation—Etoposide—muscle cancer	0.00224	0.0145	CcSEcCtD
Epinephrine—Local reaction—Doxorubicin—muscle cancer	0.00219	0.0142	CcSEcCtD
Epinephrine—SLC22A1—renal system—muscle cancer	0.00214	0.0242	CbGeAlD
Epinephrine—ADRA1B—head—muscle cancer	0.00194	0.0219	CbGeAlD
Epinephrine—ADRA1D—head—muscle cancer	0.0019	0.0215	CbGeAlD
Epinephrine—ADRB1—cardiac atrium—muscle cancer	0.00185	0.0209	CbGeAlD
Epinephrine—Necrosis—Methotrexate—muscle cancer	0.00179	0.0116	CcSEcCtD
Epinephrine—Ventricular arrhythmia—Doxorubicin—muscle cancer	0.00164	0.0106	CcSEcCtD
Epinephrine—ADRA1A—renal system—muscle cancer	0.00163	0.0184	CbGeAlD
Epinephrine—Extravasation—Methotrexate—muscle cancer	0.00161	0.0104	CcSEcCtD
Epinephrine—Acute coronary syndrome—Vincristine—muscle cancer	0.00159	0.0103	CcSEcCtD
Epinephrine—Myocardial infarction—Vincristine—muscle cancer	0.00158	0.0103	CcSEcCtD
Epinephrine—ADRA2C—renal system—muscle cancer	0.00155	0.0176	CbGeAlD
Epinephrine—Sweating—Vincristine—muscle cancer	0.00155	0.01	CcSEcCtD
Epinephrine—SLC22A1—vagina—muscle cancer	0.00155	0.0175	CbGeAlD
Epinephrine—Necrosis—Doxorubicin—muscle cancer	0.00155	0.01	CcSEcCtD
Epinephrine—Flushing—Dactinomycin—muscle cancer	0.00151	0.00976	CcSEcCtD
Epinephrine—SLC22A5—renal system—muscle cancer	0.00149	0.0168	CbGeAlD
Epinephrine—Hallucination—Vincristine—muscle cancer	0.00144	0.00934	CcSEcCtD
Epinephrine—Hypoaesthesia—Vincristine—muscle cancer	0.00144	0.00934	CcSEcCtD
Epinephrine—SLC22A1—head—muscle cancer	0.00143	0.0162	CbGeAlD
Epinephrine—Sweating increased—Etoposide—muscle cancer	0.00143	0.00926	CcSEcCtD
Epinephrine—Erythema—Dactinomycin—muscle cancer	0.00141	0.00915	CcSEcCtD
Epinephrine—Extravasation—Doxorubicin—muscle cancer	0.00139	0.00901	CcSEcCtD
Epinephrine—ADRA2C—cardiac atrium—muscle cancer	0.00139	0.0157	CbGeAlD
Epinephrine—ADRB1—head—muscle cancer	0.00138	0.0156	CbGeAlD
Epinephrine—CYP1A2—renal system—muscle cancer	0.00135	0.0152	CbGeAlD
Epinephrine—Ventricular extrasystoles—Doxorubicin—muscle cancer	0.00134	0.0087	CcSEcCtD
Epinephrine—Skin exfoliation—Methotrexate—muscle cancer	0.00134	0.00866	CcSEcCtD
Epinephrine—SLC22A5—cardiac atrium—muscle cancer	0.00133	0.0151	CbGeAlD
Epinephrine—Acute coronary syndrome—Etoposide—muscle cancer	0.00129	0.00835	CcSEcCtD
Epinephrine—Renal failure—Etoposide—muscle cancer	0.00129	0.00833	CcSEcCtD
Epinephrine—Myocardial infarction—Etoposide—muscle cancer	0.00128	0.00831	CcSEcCtD
Epinephrine—Mental disorder—Vincristine—muscle cancer	0.00127	0.00823	CcSEcCtD
Epinephrine—Pulmonary oedema—Methotrexate—muscle cancer	0.00125	0.00808	CcSEcCtD
Epinephrine—ADRA2C—tendon—muscle cancer	0.00121	0.0137	CbGeAlD
Epinephrine—Hypoaesthesia—Etoposide—muscle cancer	0.00117	0.00757	CcSEcCtD
Epinephrine—Agitation—Vincristine—muscle cancer	0.00116	0.00751	CcSEcCtD
Epinephrine—SLC22A5—tendon—muscle cancer	0.00116	0.0131	CbGeAlD
Epinephrine—Skin exfoliation—Doxorubicin—muscle cancer	0.00116	0.0075	CcSEcCtD
Epinephrine—ADRA2C—vagina—muscle cancer	0.00112	0.0127	CbGeAlD
Epinephrine—ADRA2A—cardiac atrium—muscle cancer	0.00111	0.0125	CbGeAlD
Epinephrine—Flushing—Etoposide—muscle cancer	0.00109	0.00706	CcSEcCtD
Epinephrine—Hypertension—Vincristine—muscle cancer	0.00109	0.00706	CcSEcCtD
Epinephrine—ADRA1A—head—muscle cancer	0.00109	0.0123	CbGeAlD
Epinephrine—Pulmonary oedema—Doxorubicin—muscle cancer	0.00108	0.00699	CcSEcCtD
Epinephrine—SLC22A5—vagina—muscle cancer	0.00108	0.0122	CbGeAlD
Epinephrine—Cerebrovascular accident—Methotrexate—muscle cancer	0.00104	0.00672	CcSEcCtD
Epinephrine—ADRA2C—head—muscle cancer	0.00104	0.0117	CbGeAlD
Epinephrine—Nervous system disorder—Vincristine—muscle cancer	0.00101	0.00654	CcSEcCtD
Epinephrine—ADRA2C—testis—muscle cancer	0.001	0.0113	CbGeAlD
Epinephrine—Hyperhidrosis—Vincristine—muscle cancer	0.000997	0.00645	CcSEcCtD
Epinephrine—CYP3A4—renal system—muscle cancer	0.000975	0.011	CbGeAlD
Epinephrine—ADRA2A—tendon—muscle cancer	0.000967	0.0109	CbGeAlD
Epinephrine—SLC22A5—testis—muscle cancer	0.000961	0.0109	CbGeAlD
Epinephrine—Insomnia—Vincristine—muscle cancer	0.000933	0.00603	CcSEcCtD
Epinephrine—Renal impairment—Doxorubicin—muscle cancer	0.000926	0.00599	CcSEcCtD
Epinephrine—Paraesthesia—Vincristine—muscle cancer	0.000926	0.00599	CcSEcCtD
Epinephrine—Hypoglycaemia—Doxorubicin—muscle cancer	0.000903	0.00584	CcSEcCtD
Epinephrine—Cerebrovascular accident—Doxorubicin—muscle cancer	0.0009	0.00582	CcSEcCtD
Epinephrine—ADRA2A—vagina—muscle cancer	0.000897	0.0101	CbGeAlD
Epinephrine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00089	0.00576	CcSEcCtD
Epinephrine—Hypertension—Etoposide—muscle cancer	0.000884	0.00572	CcSEcCtD
Epinephrine—Chest pain—Etoposide—muscle cancer	0.000871	0.00564	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000865	0.0056	CcSEcCtD
Epinephrine—ADRA2A—head—muscle cancer	0.000829	0.00937	CbGeAlD
Epinephrine—Tachycardia—Etoposide—muscle cancer	0.000815	0.00528	CcSEcCtD
Epinephrine—Skin disorder—Etoposide—muscle cancer	0.000811	0.00525	CcSEcCtD
Epinephrine—Hyperhidrosis—Etoposide—muscle cancer	0.000808	0.00523	CcSEcCtD
Epinephrine—Hypokalaemia—Doxorubicin—muscle cancer	0.000802	0.00519	CcSEcCtD
Epinephrine—ADRA2A—testis—muscle cancer	0.000801	0.00906	CbGeAlD
Epinephrine—Drowsiness—Methotrexate—muscle cancer	0.000785	0.00508	CcSEcCtD
Epinephrine—Renal failure—Methotrexate—muscle cancer	0.000771	0.00499	CcSEcCtD
Epinephrine—Sweating—Methotrexate—muscle cancer	0.000752	0.00487	CcSEcCtD
Epinephrine—Paraesthesia—Etoposide—muscle cancer	0.00075	0.00485	CcSEcCtD
Epinephrine—Somnolence—Etoposide—muscle cancer	0.000743	0.00481	CcSEcCtD
Epinephrine—Vomiting—Dactinomycin—muscle cancer	0.000734	0.00475	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000721	0.00467	CcSEcCtD
Epinephrine—Haemoglobin—Methotrexate—muscle cancer	0.000708	0.00458	CcSEcCtD
Epinephrine—Haemorrhage—Methotrexate—muscle cancer	0.000704	0.00456	CcSEcCtD
Epinephrine—Hyperglycaemia—Doxorubicin—muscle cancer	0.000687	0.00445	CcSEcCtD
Epinephrine—Nausea—Dactinomycin—muscle cancer	0.000686	0.00444	CcSEcCtD
Epinephrine—Dizziness—Vincristine—muscle cancer	0.000682	0.00441	CcSEcCtD
Epinephrine—Drowsiness—Doxorubicin—muscle cancer	0.000679	0.0044	CcSEcCtD
Epinephrine—Renal failure—Doxorubicin—muscle cancer	0.000668	0.00432	CcSEcCtD
Epinephrine—Vomiting—Vincristine—muscle cancer	0.000656	0.00424	CcSEcCtD
Epinephrine—Sweating—Doxorubicin—muscle cancer	0.000651	0.00421	CcSEcCtD
Epinephrine—Mental disorder—Methotrexate—muscle cancer	0.000617	0.00399	CcSEcCtD
Epinephrine—Erythema—Methotrexate—muscle cancer	0.000613	0.00397	CcSEcCtD
Epinephrine—Haemoglobin—Doxorubicin—muscle cancer	0.000613	0.00397	CcSEcCtD
Epinephrine—Nausea—Vincristine—muscle cancer	0.000613	0.00396	CcSEcCtD
Epinephrine—Haemorrhage—Doxorubicin—muscle cancer	0.00061	0.00395	CcSEcCtD
Epinephrine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000607	0.00393	CcSEcCtD
Epinephrine—Flushing—Doxorubicin—muscle cancer	0.000566	0.00366	CcSEcCtD
Epinephrine—Dizziness—Etoposide—muscle cancer	0.000552	0.00357	CcSEcCtD
Epinephrine—Arrhythmia—Doxorubicin—muscle cancer	0.000545	0.00353	CcSEcCtD
Epinephrine—Mental disorder—Doxorubicin—muscle cancer	0.000534	0.00346	CcSEcCtD
Epinephrine—Vomiting—Etoposide—muscle cancer	0.000531	0.00344	CcSEcCtD
Epinephrine—Erythema—Doxorubicin—muscle cancer	0.000531	0.00343	CcSEcCtD
Epinephrine—Chest pain—Methotrexate—muscle cancer	0.000522	0.00338	CcSEcCtD
Epinephrine—Tension—Doxorubicin—muscle cancer	0.000521	0.00337	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000518	0.00335	CcSEcCtD
Epinephrine—Nervousness—Doxorubicin—muscle cancer	0.000516	0.00334	CcSEcCtD
Epinephrine—Nausea—Etoposide—muscle cancer	0.000496	0.00321	CcSEcCtD
Epinephrine—Nervous system disorder—Methotrexate—muscle cancer	0.000491	0.00317	CcSEcCtD
Epinephrine—Agitation—Doxorubicin—muscle cancer	0.000488	0.00316	CcSEcCtD
Epinephrine—Skin disorder—Methotrexate—muscle cancer	0.000486	0.00314	CcSEcCtD
Epinephrine—Hyperhidrosis—Methotrexate—muscle cancer	0.000484	0.00313	CcSEcCtD
Epinephrine—Palpitations—Doxorubicin—muscle cancer	0.000469	0.00304	CcSEcCtD
Epinephrine—Hypertension—Doxorubicin—muscle cancer	0.000458	0.00297	CcSEcCtD
Epinephrine—Insomnia—Methotrexate—muscle cancer	0.000453	0.00293	CcSEcCtD
Epinephrine—Chest pain—Doxorubicin—muscle cancer	0.000452	0.00292	CcSEcCtD
Epinephrine—Paraesthesia—Methotrexate—muscle cancer	0.000449	0.00291	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000449	0.0029	CcSEcCtD
Epinephrine—Somnolence—Methotrexate—muscle cancer	0.000445	0.00288	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000432	0.0028	CcSEcCtD
Epinephrine—Nervous system disorder—Doxorubicin—muscle cancer	0.000425	0.00275	CcSEcCtD
Epinephrine—Tachycardia—Doxorubicin—muscle cancer	0.000423	0.00274	CcSEcCtD
Epinephrine—Skin disorder—Doxorubicin—muscle cancer	0.000421	0.00272	CcSEcCtD
Epinephrine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000419	0.00271	CcSEcCtD
Epinephrine—Insomnia—Doxorubicin—muscle cancer	0.000392	0.00254	CcSEcCtD
Epinephrine—Paraesthesia—Doxorubicin—muscle cancer	0.000389	0.00252	CcSEcCtD
Epinephrine—Somnolence—Doxorubicin—muscle cancer	0.000385	0.00249	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000374	0.00242	CcSEcCtD
Epinephrine—Dizziness—Methotrexate—muscle cancer	0.000331	0.00214	CcSEcCtD
Epinephrine—Vomiting—Methotrexate—muscle cancer	0.000318	0.00206	CcSEcCtD
Epinephrine—Nausea—Methotrexate—muscle cancer	0.000297	0.00192	CcSEcCtD
Epinephrine—ADRA2C—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000289	0.00239	CbGpPWpGaD
Epinephrine—Dizziness—Doxorubicin—muscle cancer	0.000287	0.00185	CcSEcCtD
Epinephrine—ADRA2B—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.000286	0.00237	CbGpPWpGaD
Epinephrine—TNF—Folate Metabolism—TP53—muscle cancer	0.000286	0.00236	CbGpPWpGaD
Epinephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000285	0.00236	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—ANGPT2—muscle cancer	0.000284	0.00235	CbGpPWpGaD
Epinephrine—Vomiting—Doxorubicin—muscle cancer	0.000275	0.00178	CcSEcCtD
Epinephrine—ADRBK1—Signaling by NGF—MDM2—muscle cancer	0.000273	0.00226	CbGpPWpGaD
Epinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000268	0.00222	CbGpPWpGaD
Epinephrine—ADRA2C—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.000268	0.00221	CbGpPWpGaD
Epinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000265	0.0022	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR ligand binding—PTCH1—muscle cancer	0.000265	0.00219	CbGpPWpGaD
Epinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000262	0.00217	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—PTCH1—muscle cancer	0.00026	0.00215	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—FOXO1—muscle cancer	0.000259	0.00214	CbGpPWpGaD
Epinephrine—Nausea—Doxorubicin—muscle cancer	0.000257	0.00167	CcSEcCtD
Epinephrine—ADRA2A—G alpha (i) signalling events—CNR1—muscle cancer	0.000253	0.00209	CbGpPWpGaD
Epinephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000253	0.00209	CbGpPWpGaD
Epinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000248	0.00205	CbGpPWpGaD
Epinephrine—TNF—Alzheimers Disease—TP53—muscle cancer	0.000247	0.00205	CbGpPWpGaD
Epinephrine—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000245	0.00203	CbGpPWpGaD
Epinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000244	0.00202	CbGpPWpGaD
Epinephrine—ADRBK1—GPCR downstream signaling—CNR1—muscle cancer	0.000242	0.002	CbGpPWpGaD
Epinephrine—ADRB1—GPCR ligand binding—PTCH1—muscle cancer	0.000241	0.002	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR ligand binding—PTCH1—muscle cancer	0.000239	0.00198	CbGpPWpGaD
Epinephrine—ADRB2—GPCR ligand binding—PTCH1—muscle cancer	0.000236	0.00196	CbGpPWpGaD
Epinephrine—TNF—Apoptosis—TP53—muscle cancer	0.000236	0.00195	CbGpPWpGaD
Epinephrine—ADRA2A—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000235	0.00194	CbGpPWpGaD
Epinephrine—CYP1A2—Tryptophan metabolism—MDM2—muscle cancer	0.000233	0.00192	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—ENO2—muscle cancer	0.000231	0.00192	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—ANGPT2—muscle cancer	0.00023	0.00191	CbGpPWpGaD
Epinephrine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	0.000224	0.00186	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR ligand binding—CNR1—muscle cancer	0.000224	0.00185	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR ligand binding—PTCH1—muscle cancer	0.000224	0.00185	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR ligand binding—PTCH1—muscle cancer	0.00022	0.00182	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—CNR1—muscle cancer	0.00022	0.00182	CbGpPWpGaD
Epinephrine—PAH—Disease—FOXO1—muscle cancer	0.000219	0.00181	CbGpPWpGaD
Epinephrine—ADRA2A—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.000217	0.0018	CbGpPWpGaD
Epinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000217	0.00179	CbGpPWpGaD
Epinephrine—TNF—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000213	0.00176	CbGpPWpGaD
Epinephrine—ADRA1B—AMPK Signaling—TP53—muscle cancer	0.000212	0.00175	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—HMGA1—muscle cancer	0.00021	0.00174	CbGpPWpGaD
Epinephrine—CYP1A2—Arachidonic acid metabolism—PTGS2—muscle cancer	0.00021	0.00174	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—PTCH1—muscle cancer	0.000209	0.00173	CbGpPWpGaD
Epinephrine—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000205	0.0017	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—FOXO4—muscle cancer	0.000204	0.00169	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—KIDINS220—muscle cancer	0.000204	0.00169	CbGpPWpGaD
Epinephrine—ADRB1—GPCR ligand binding—CNR1—muscle cancer	0.000204	0.00169	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR ligand binding—CNR1—muscle cancer	0.000202	0.00167	CbGpPWpGaD
Epinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000201	0.00167	CbGpPWpGaD
Epinephrine—ADRB2—GPCR ligand binding—CNR1—muscle cancer	0.000199	0.00165	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—KIT—muscle cancer	0.000197	0.00163	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR ligand binding—PTCH1—muscle cancer	0.000195	0.00162	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—CNR1—muscle cancer	0.000194	0.00161	CbGpPWpGaD
Epinephrine—TNF—SIDS Susceptibility Pathways—VEGFA—muscle cancer	0.00019	0.00157	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR ligand binding—CNR1—muscle cancer	0.000189	0.00156	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—FOXO4—muscle cancer	0.000189	0.00156	CbGpPWpGaD
Epinephrine—ADRA1A—AMPK Signaling—TP53—muscle cancer	0.000188	0.00156	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—KIDINS220—muscle cancer	0.000186	0.00154	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR ligand binding—CNR1—muscle cancer	0.000186	0.00154	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—KIDINS220—muscle cancer	0.000184	0.00153	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—KIDINS220—muscle cancer	0.000182	0.00151	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—PTCH1—muscle cancer	0.000182	0.0015	CbGpPWpGaD
Epinephrine—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	0.000179	0.00149	CbGpPWpGaD
Epinephrine—TNF—Spinal Cord Injury—TP53—muscle cancer	0.000179	0.00149	CbGpPWpGaD
Epinephrine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	0.000177	0.00146	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—CNR1—muscle cancer	0.000176	0.00146	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—KIDINS220—muscle cancer	0.000172	0.00142	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—FH—muscle cancer	0.000171	0.00141	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—KIDINS220—muscle cancer	0.000169	0.0014	CbGpPWpGaD
Epinephrine—PAH—Disease—KIT—muscle cancer	0.000167	0.00138	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—FH—muscle cancer	0.000166	0.00137	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—FOXO1—muscle cancer	0.000166	0.00137	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR ligand binding—CNR1—muscle cancer	0.000165	0.00137	CbGpPWpGaD
Epinephrine—SLC22A2—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000165	0.00136	CbGpPWpGaD
Epinephrine—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000162	0.00134	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—FH—muscle cancer	0.000159	0.00132	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—MDM2—muscle cancer	0.000155	0.00129	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—PTCH1—muscle cancer	0.000154	0.00127	CbGpPWpGaD
Epinephrine—SLC22A1—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000153	0.00127	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—CNR1—muscle cancer	0.000153	0.00127	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—FOXO1—muscle cancer	0.000151	0.00125	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—KIDINS220—muscle cancer	0.00015	0.00125	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—IGF2—muscle cancer	0.000148	0.00122	CbGpPWpGaD
Epinephrine—TNF—Apoptosis—TP53—muscle cancer	0.000144	0.00119	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—KIDINS220—muscle cancer	0.00014	0.00116	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—FOXO1—muscle cancer	0.000139	0.00115	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—IGF2—muscle cancer	0.000138	0.00114	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—PTCH1—muscle cancer	0.000136	0.00113	CbGpPWpGaD
Epinephrine—TNF—MAPK Signaling Pathway—TP53—muscle cancer	0.000135	0.00112	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—FH—muscle cancer	0.000135	0.00112	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—FOXO4—muscle cancer	0.000132	0.00109	CbGpPWpGaD
Epinephrine—PAH—Disease—MDM2—muscle cancer	0.000131	0.00109	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—CNR1—muscle cancer	0.00013	0.00107	CbGpPWpGaD
Epinephrine—PAH—Disease—PTGS2—muscle cancer	0.000127	0.00105	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—CNR1—muscle cancer	0.000126	0.00105	CbGpPWpGaD
Epinephrine—SLC22A2—Neuronal System—MDM2—muscle cancer	0.000126	0.00104	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—PTCH1—muscle cancer	0.000124	0.00103	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—PTCH1—muscle cancer	0.000123	0.00102	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—PTCH1—muscle cancer	0.000123	0.00102	CbGpPWpGaD
Epinephrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000122	0.00101	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—PTCH1—muscle cancer	0.000121	0.001	CbGpPWpGaD
Epinephrine—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.00012	0.000994	CbGpPWpGaD
Epinephrine—SLC22A1—Neuronal System—MDM2—muscle cancer	0.000118	0.000973	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—CNR1—muscle cancer	0.000115	0.000953	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—KIT—muscle cancer	0.000115	0.000952	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—CNR1—muscle cancer	0.000115	0.00095	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—PTCH1—muscle cancer	0.000115	0.000949	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—CNR1—muscle cancer	0.000114	0.000945	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—PTCH1—muscle cancer	0.000113	0.000934	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—CNR1—muscle cancer	0.000113	0.000933	CbGpPWpGaD
Epinephrine—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000112	0.000929	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—IGF2—muscle cancer	0.000112	0.000927	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.00011	0.000914	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—CNR1—muscle cancer	0.000107	0.000882	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—KIT—muscle cancer	0.000106	0.000879	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—FOXO4—muscle cancer	0.000106	0.000878	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—IGF2—muscle cancer	0.000106	0.000877	CbGpPWpGaD
Epinephrine—PAH—Metabolism—PTGS2—muscle cancer	0.000106	0.000877	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—CNR1—muscle cancer	0.000105	0.000868	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—CNR1—muscle cancer	0.000105	0.000866	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CNR1—muscle cancer	0.000104	0.000862	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—CNR1—muscle cancer	0.000104	0.000858	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—CNR1—muscle cancer	0.000102	0.000847	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—PTCH1—muscle cancer	0.0001	0.00083	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—FOXO1—muscle cancer	9.76e-05	0.000808	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—CNR1—muscle cancer	9.68e-05	0.000801	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—MED12—muscle cancer	9.64e-05	0.000798	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—CNR1—muscle cancer	9.53e-05	0.000789	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	9.44e-05	0.000781	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—MED12—muscle cancer	9.38e-05	0.000776	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—CNR1—muscle cancer	9.32e-05	0.000771	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—PTCH1—muscle cancer	9.32e-05	0.000771	CbGpPWpGaD
Epinephrine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	9.11e-05	0.000754	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—MDM2—muscle cancer	9.06e-05	0.00075	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—MED12—muscle cancer	8.98e-05	0.000744	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—ENO2—muscle cancer	8.79e-05	0.000727	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—FH—muscle cancer	8.71e-05	0.000721	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—CNR1—muscle cancer	8.66e-05	0.000717	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—ENO2—muscle cancer	8.55e-05	0.000708	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IGF2—muscle cancer	8.51e-05	0.000704	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—CNR1—muscle cancer	8.46e-05	0.000701	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—MDM2—muscle cancer	8.36e-05	0.000692	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—ENO2—muscle cancer	8.19e-05	0.000678	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—PTGS2—muscle cancer	8.06e-05	0.000667	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—PTCH1—muscle cancer	8.03e-05	0.000665	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—CNR1—muscle cancer	7.86e-05	0.000651	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—FOXO1—muscle cancer	7.83e-05	0.000648	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—MED12—muscle cancer	7.62e-05	0.00063	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—VEGFA—muscle cancer	7.55e-05	0.000625	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—FH—muscle cancer	7.44e-05	0.000616	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—KIT—muscle cancer	7.43e-05	0.000615	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PTCH1—muscle cancer	7.32e-05	0.000606	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PTCH1—muscle cancer	7.25e-05	0.0006	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PTCH1—muscle cancer	7.16e-05	0.000593	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—ENO2—muscle cancer	6.94e-05	0.000575	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—FOXO4—muscle cancer	6.91e-05	0.000572	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CNR1—muscle cancer	6.78e-05	0.000561	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PTCH1—muscle cancer	6.78e-05	0.000561	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PTCH1—muscle cancer	6.67e-05	0.000552	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—FOXO4—muscle cancer	6.3e-05	0.000521	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—FOXO4—muscle cancer	6.24e-05	0.000516	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—VEGFA—muscle cancer	6.19e-05	0.000513	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CNR1—muscle cancer	6.18e-05	0.000511	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—FOXO4—muscle cancer	6.16e-05	0.00051	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CNR1—muscle cancer	6.12e-05	0.000507	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CNR1—muscle cancer	6.04e-05	0.0005	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—KIT—muscle cancer	5.97e-05	0.000494	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PTCH1—muscle cancer	5.92e-05	0.00049	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—MDM2—muscle cancer	5.85e-05	0.000485	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—FOXO4—muscle cancer	5.83e-05	0.000482	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—VEGFA—muscle cancer	5.78e-05	0.000479	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—FH—muscle cancer	5.74e-05	0.000475	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—FOXO4—muscle cancer	5.73e-05	0.000475	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CNR1—muscle cancer	5.72e-05	0.000473	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CNR1—muscle cancer	5.63e-05	0.000466	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IGF2—muscle cancer	5.54e-05	0.000459	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PTCH1—muscle cancer	5.5e-05	0.000456	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—FOXO1—muscle cancer	5.1e-05	0.000422	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—FOXO4—muscle cancer	5.09e-05	0.000422	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IGF2—muscle cancer	5.05e-05	0.000418	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IGF2—muscle cancer	5.01e-05	0.000414	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CNR1—muscle cancer	5e-05	0.000414	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IGF2—muscle cancer	4.94e-05	0.000409	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—MED12—muscle cancer	4.92e-05	0.000407	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—FOXO4—muscle cancer	4.73e-05	0.000392	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MDM2—muscle cancer	4.7e-05	0.000389	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—VEGFA—muscle cancer	4.7e-05	0.000389	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—TP53—muscle cancer	4.68e-05	0.000387	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IGF2—muscle cancer	4.68e-05	0.000387	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—FOXO1—muscle cancer	4.65e-05	0.000385	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CNR1—muscle cancer	4.65e-05	0.000384	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—FOXO1—muscle cancer	4.61e-05	0.000381	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IGF2—muscle cancer	4.6e-05	0.000381	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—FOXO1—muscle cancer	4.55e-05	0.000376	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ENO2—muscle cancer	4.49e-05	0.000371	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—VEGFA—muscle cancer	4.45e-05	0.000368	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—TP53—muscle cancer	4.37e-05	0.000362	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—FOXO1—muscle cancer	4.3e-05	0.000356	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—FOXO1—muscle cancer	4.24e-05	0.000351	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—MED12—muscle cancer	4.2e-05	0.000348	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IGF2—muscle cancer	4.09e-05	0.000338	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—KIT—muscle cancer	3.89e-05	0.000322	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ENO2—muscle cancer	3.83e-05	0.000317	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IGF2—muscle cancer	3.8e-05	0.000314	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—FOXO1—muscle cancer	3.76e-05	0.000311	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—VEGFA—muscle cancer	3.57e-05	0.000295	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TP53—muscle cancer	3.55e-05	0.000294	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—KIT—muscle cancer	3.54e-05	0.000293	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—KIT—muscle cancer	3.51e-05	0.000291	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.51e-05	0.00029	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—FOXO1—muscle cancer	3.5e-05	0.000289	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—KIT—muscle cancer	3.47e-05	0.000287	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TP53—muscle cancer	3.36e-05	0.000278	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—KIT—muscle cancer	3.28e-05	0.000271	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—MED12—muscle cancer	3.24e-05	0.000269	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—KIT—muscle cancer	3.23e-05	0.000267	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MDM2—muscle cancer	3.06e-05	0.000253	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PTGS2—muscle cancer	3.06e-05	0.000253	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3e-05	0.000248	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PTGS2—muscle cancer	2.98e-05	0.000246	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ENO2—muscle cancer	2.96e-05	0.000245	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—KIT—muscle cancer	2.87e-05	0.000237	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PTGS2—muscle cancer	2.85e-05	0.000236	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MDM2—muscle cancer	2.79e-05	0.000231	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MDM2—muscle cancer	2.76e-05	0.000229	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MDM2—muscle cancer	2.73e-05	0.000226	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TP53—muscle cancer	2.7e-05	0.000223	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—KIT—muscle cancer	2.66e-05	0.00022	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MDM2—muscle cancer	2.58e-05	0.000214	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MDM2—muscle cancer	2.54e-05	0.00021	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTGS2—muscle cancer	2.42e-05	0.0002	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—VEGFA—muscle cancer	2.33e-05	0.000192	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MDM2—muscle cancer	2.26e-05	0.000187	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—VEGFA—muscle cancer	2.12e-05	0.000175	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—VEGFA—muscle cancer	2.1e-05	0.000174	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MDM2—muscle cancer	2.1e-05	0.000174	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—VEGFA—muscle cancer	2.07e-05	0.000172	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—VEGFA—muscle cancer	1.96e-05	0.000162	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—VEGFA—muscle cancer	1.93e-05	0.00016	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TP53—muscle cancer	1.76e-05	0.000145	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—VEGFA—muscle cancer	1.71e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TP53—muscle cancer	1.6e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—VEGFA—muscle cancer	1.59e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TP53—muscle cancer	1.59e-05	0.000131	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TP53—muscle cancer	1.57e-05	0.00013	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTGS2—muscle cancer	1.56e-05	0.000129	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TP53—muscle cancer	1.48e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TP53—muscle cancer	1.46e-05	0.000121	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTGS2—muscle cancer	1.33e-05	0.00011	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TP53—muscle cancer	1.3e-05	0.000107	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TP53—muscle cancer	1.2e-05	9.96e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTGS2—muscle cancer	1.03e-05	8.53e-05	CbGpPWpGaD
